PMC:7321036 / 78602-79167 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T599","span":{"begin":78,"end":83},"obj":"Body_part"},{"id":"T600","span":{"begin":245,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A599","pred":"fma_id","subj":"T599","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A600","pred":"fma_id","subj":"T600","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Viruses (University of Freiburg, Germany)\nFor infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T335","span":{"begin":46,"end":55},"obj":"Disease"},{"id":"T336","span":{"begin":85,"end":93},"obj":"Disease"},{"id":"T337","span":{"begin":208,"end":216},"obj":"Disease"},{"id":"T338","span":{"begin":309,"end":317},"obj":"Disease"}],"attributes":[{"id":"A335","pred":"mondo_id","subj":"T335","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A336","pred":"mondo_id","subj":"T336","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A337","pred":"mondo_id","subj":"T337","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A338","pred":"mondo_id","subj":"T338","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Viruses (University of Freiburg, Germany)\nFor infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1101","span":{"begin":0,"end":7},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T1102","span":{"begin":71,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0002172"},{"id":"T1103","span":{"begin":71,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0051943"},{"id":"T1104","span":{"begin":71,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0051958"},{"id":"T1105","span":{"begin":71,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0051960"},{"id":"T1106","span":{"begin":78,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T1107","span":{"begin":237,"end":250},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"}],"text":"Viruses (University of Freiburg, Germany)\nFor infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1758","span":{"begin":108,"end":113},"obj":"Gene"},{"id":"1759","span":{"begin":85,"end":95},"obj":"Species"},{"id":"1760","span":{"begin":208,"end":218},"obj":"Species"},{"id":"1761","span":{"begin":309,"end":319},"obj":"Species"},{"id":"1762","span":{"begin":254,"end":258},"obj":"Chemical"},{"id":"1763","span":{"begin":46,"end":55},"obj":"Disease"},{"id":"1764","span":{"begin":71,"end":77},"obj":"CellLine"},{"id":"1765","span":{"begin":242,"end":244},"obj":"CellLine"}],"attributes":[{"id":"A1758","pred":"tao:has_database_id","subj":"1758","obj":"Gene:3837"},{"id":"A1759","pred":"tao:has_database_id","subj":"1759","obj":"Tax:2697049"},{"id":"A1760","pred":"tao:has_database_id","subj":"1760","obj":"Tax:2697049"},{"id":"A1761","pred":"tao:has_database_id","subj":"1761","obj":"Tax:2697049"},{"id":"A1763","pred":"tao:has_database_id","subj":"1763","obj":"MESH:D007239"},{"id":"A1764","pred":"tao:has_database_id","subj":"1764","obj":"CVCL:0025"},{"id":"A1765","pred":"tao:has_database_id","subj":"1765","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Viruses (University of Freiburg, Germany)\nFor infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T715","span":{"begin":0,"end":41},"obj":"Sentence"},{"id":"T716","span":{"begin":42,"end":207},"obj":"Sentence"},{"id":"T717","span":{"begin":208,"end":284},"obj":"Sentence"},{"id":"T718","span":{"begin":285,"end":565},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Viruses (University of Freiburg, Germany)\nFor infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05)."}